Z-0998-2020 Class II Terminated

Recalled by Roche Diabetes Care, Inc. — Indianapolis, IN

FDA device recall Z-0998-2020 was initiated by Roche Diabetes Care, Inc. on Dec 11, 2019 and is designated Class II. Reason for recall: Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions The recall status is terminated (terminated Jul 8, 2022). Affected quantity: 92,836 vials.

Recall Details

Product Type
Devices
Report Date
Feb 12, 2020
Initiation Date
Dec 11, 2019
Termination Date
Jul 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
92,836 vials

Product Description

Accu-Chek Aviva Plus Retail Strips 50 ct - intended for Blood Glucose Monitoring System Catalog Number: 06908217001

Reason for Recall

Inability to dose the test strips, may result in a temporary inability to get a result that could lead to a delay in treatment and/or therapy decisions

Distribution Pattern

Nationwide: Foreign: Austalia, India

Code Information

Lot Number:498315 NDC: 65702-0407-10 UPC: 3-65702-40710-7

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0998-2020
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0998-2020. Report a data issue: hello@regdatalab.com.